Dr. Korenko, CEO of Vivos Inc-IsoPet®
Maxximus came with a large tumor on his leg in 2024. In the 8 weeks post treatment the tumor has shrunk and Maxximus is doing well!
Large Spindle Cell Tumor
A single IsoPet® treatment was administered at Vista Veterinary Hospital in Kennewick, WA.
“Moose had 6 wonderful years after his IsoPet treatment for a soft tissue sarcoma at the University of Missouri. Thank you for giving us that time.” - Pam Dawson, pet parent of Moose
Soft Tissue Sarcoma
Single IsoPet® administered at the University of Missouri in 2018
Moose was a 6 year cancer survivor before passing away in 2024 of diabetes.
Moose was also featured on CBS News to help bring awareness to pet cancer and the importance of early detection
"She is doing very well. She gets ridden a lot and is doing well. ZERO signs of recurrence of the sarcoid. I will always be so grateful to you for all you did for Summer Solstice." - Barb, owner of Summer Solstice
Equine Sarcoid on the back of neck
Single IsoPet® administered at the University of Missouri in 2021
Summer Solstice remains cancer free since 2021 with no signs of recurrence.
“Great success story. Brew and I thank you for his return to a more normal life”. - Brew's Pet Parent
Soft Tissue Sarcoma- At 8 weeks post treatment Brew's tumor had shrunk and at 15 weeks post-treatment there was no observed recurrence of tumor.
Brew was facing leg amputation but a single IsoPet® treatment in 2022 saved his leg. Brew is now healthy and happy.
"I am beyond THRILLED" - Francis's pet mom
“I saw Francis today for a recheck. He looks great and mom is thrilled with how he is doing. The fur is growing back around the treated area. There is no skin sloughing, no skin damage." - Dr. Rebeca Krimins, DVM Johns Hopkins Hospital
Carcinoma - left front leg, 3 weeks rapid growth before a single IsoPet® treatment in 2022 at Johns Hopkins Hospital.
Picture taken one month after treatment, Francis was back to himself!
Oliver had a previous tumor and a prior traditional cancer treatment left him with an amputated left hind leg to attempt to remove aggressive tumor. When another tumor surfaced on his other leg his pet parents contacted Johns Hopkins Hospital and performed IsoPet® Precision Radionuclide Therapy™ in 2022.
"I, 100% agreed with performing the Y-90 hydrogel treatment because without it, the cat’s tumor would certainly continue to grow and take his life. With the treatment, we were hopefully giving Oliver a longer time frame with a better quality of life. Fingers crossed we give lots more time to this kitty to spend with his family.” - Rebecca Krimins DVM, Johns Hopkins Hospital
The sarcoma in his leg, grew rapidly in less than 2 months and was successfully treated with one IsoPet® treatment.
Picture was taken post surgery while Oliver was resting at home and according to his pet parents he was very happy!
After several attempts and chemotherapy, Drakes pet parent travelled from Alaska to Vista Veterinary Hospital in Kennewick, WA.
Spindle Cell Sarcoma - right side of the face by the nose
The owner is a Veterinarian and at 17 days following the IsoPet® treatment reported “There is a continuing decrease in the neoplastic mass. I suspect that some of the residual swelling is inflammatory in nature. The skin is intact, no ulceration or necrosis. Therapy was effective" - Drake's pet parent and veterinarian.
“She is doing really well, totally back how she was before we found the tumor. The tumor is fully gone now and the hair in that area has grown back, we didn’t see any side effects from the treatment at all. She can run and walk a few miles each day, eat well and happy 😊” - Annie's Pet Parent
Soft Tissue Sarcoma - on the paw of a Sheltie
A tumor at the same location on the toe was removed 3 years prior to IsoPet® treatment. When another tumor resurfaced they tried IsoPet® Precision Radionuclide Therapy™ - PRnT™ in 2021 and the tumor never resurfaced again and Annie has remained cancer free for 3 years before passing from an unrelated illness.
IsoPet® is a international registered trademark of Vivos Inc. (OTCQB:RDGL)
Copyright © 2023 Vivos, Inc. - All Rights Reserved